Use Options For a Chance To Buy GEVA at a 25% Discount

Looking back to 2 days ago, Synageva BioPharma Corp (GEVA) priced a 3000000 share secondary stock offering at $94.19 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Thursday, the stock is now 8.3% above the offering price..